New Therapies and Prevention Strategies for Genital Herpes | Zendy

Anna Wald | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

New Therapies and Prevention Strategies for Genital Herpes

Author(s) -

Anna Wald

Publication year - 1999

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/514723

Subject(s) - famciclovir , medicine , genital herpes , herpes simplex virus , herpes genitalis , transmission (telecommunications) , sex organ , valaciclovir , sexual transmission , immunology , antiviral therapy , serology , virology , hsl and hsv , herpesviridae , dermatology , viral disease , virus , antibody , human immunodeficiency virus (hiv) , biology , microbicide , chronic hepatitis , electrical engineering , genetics , engineering

Genital herpes is among the most prevalent sexually transmitted diseases. Optimal management of genital herpes includes accurate diagnosis, antiviral therapy, and counseling of patients about complications and transmission of herpes simplex virus (HSV). Antiviral therapy offers significant palliation, and the option of episodic or suppressive treatment should be offered to all patients with genital herpes. Valacyclovir and famciclovir are two newer antiviral agents that are effective and safe for the treatment of genital herpes. Prevention strategies for sexual and perinatal transmission of HSV have not been well defined. Availability of type-specific serological tests for HSV antibodies may assist in identifying persons at risk for acquiring or transmitting HSV infection. Further research is needed to define strategies to prevent the spread of this epidemic infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research